 |
PDBsum entry 4zs0
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Discovery of a selective aurora a kinase inhibitor by virtual screening.
|
 |
|
Authors
|
 |
F.Kilchmann,
M.J.Marcaida,
S.Kotak,
T.Schick,
S.D.Boss,
M.Awale,
P.Gönczy,
J.L.Reymond.
|
 |
|
Ref.
|
 |
J Med Chem, 2016,
59,
7188-7211.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Here we report the discovery of a selective inhibitor of Aurora A, a key
regulator of cell division and potential anticancer target. We used the atom
category extended ligand overlap score (xLOS), a 3D ligand-based virtual
screening method recently developed in our group, to select 437 shape and
pharmacophore analogs of reference kinase inhibitors. Biochemical screening
uncovered two inhibitor series with scaffolds unprecedented among kinase
inhibitors. One of them was successfully optimized by structure-based design to
a potent Aurora A inhibitor (IC50 = 2 nM) with very high kinome selectivity for
Aurora kinases. This inhibitor locks Aurora A in an inactive conformation and
disrupts binding to its activator protein TPX2, which impairs Aurora A
localization at the mitotic spindle and induces cell division defects. This
phenotype can be rescued by inhibitor-resistant Aurora A mutants. The inhibitor
furthermore does not induce Aurora B specific effects in cells.
|
 |
|
|
|
|
 |